Cite
MLA Citation
Patrick A Flume et al.. “Long-term safety and efficacy of tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study.” Lancet, vol. 9, no. 7, 2021, pp. 733–746. http://access.bl.uk/ark:/81055/vdc_100133916902.0x000011